NSGCX
Price
$21.44
Change
-$0.19 (-0.88%)
Updated
Jul 13 closing price
Net Assets
1.51B
VFFSX
Price
$367.80
Change
-$2.94 (-0.79%)
Updated
Jul 13 closing price
Net Assets
1.67T
Interact to see
Advertisement

NSGCX vs VFFSX

NSGCX vs VFFSX Comparison Chart in %
View a ticker or compare two or three
VS
NSGCX vs. VFFSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NSGCX is a StrongBuy and VFFSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.67T vs. NSGCX (1.52B). VFFSX pays higher dividends than NSGCX: VFFSX (1.08) vs NSGCX (0.01). NSGCX was incepted earlier than VFFSX: NSGCX (27 years) vs VFFSX (10 years). NSGCX (1.85) is less costly to investors than VFFSX (0.01). NSGCX is a more actively managed with annual turnover of: 71.00 vs. VFFSX (2.00). NSGCX has a lower initial minimum investment than VFFSX: NSGCX (2000) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 21.07 vs. NSGCX (11.79). VFFSX return over 5 years is better than : 73.48 vs. NSGCX (23.71).
NSGCXVFFSXNSGCX / VFFSX
Total Expense Ratio1.650.0116,500%
Annual Report Gross Expense Ratio1.850.0118,500%
Fund Existence27 years10 years-
Gain YTD3.25210.68530%
Front LoadN/AN/A-
Min. Initial Investment200050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.52B1.67T0%
Annual Yield % from dividends0.011.081%
Returns for 1 year11.7921.0756%
Returns for 3 years33.7568.4549%
Returns for 5 years23.7173.4832%
Returns for 10 years95.18251.2138%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZIEX20.58N/A
N/A
Lazard International Equity Instl
CMNWX91.13N/A
N/A
Principal Capital Appreciation A
PRWCX38.43N/A
N/A
T. Rowe Price Capital Appreciation
TRZYX24.28N/A
N/A
T. Rowe Price Latin America Z
MCYSX16.25-0.50
-2.99%
NYLI Candriam Emerging Markets Eq Cl R6